144 related articles for article (PubMed ID: 21484830)
1. Demyelinating neuropathy with anti-CRMP5 antibodies predating diagnosis of breast carcinoma: favorable outcome after cancer therapy.
Samarasekera S; Rajabally YA
Muscle Nerve; 2011 May; 43(5):764-6. PubMed ID: 21484830
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases.
Dubey D; Lennon VA; Gadoth A; Pittock SJ; Flanagan EP; Schmeling JE; McKeon A; Klein CJ
Neurology; 2018 Jan; 90(2):e103-e110. PubMed ID: 29222126
[TBL] [Abstract][Full Text] [Related]
3. Amphiphysin-IgG autoimmune neuropathy: A recognizable clinicopathologic syndrome.
Dubey D; Jitprapaikulsan J; Bi H; Do Campo RV; McKeon A; Pittock SJ; Engelstad JK; Mills JR; Klein CJ
Neurology; 2019 Nov; 93(20):e1873-e1880. PubMed ID: 31624089
[TBL] [Abstract][Full Text] [Related]
4. CV2/CRMP5-antibody-related Paraneoplastic Optic Neuropathy Associated with Small-cell Lung Cancer.
Nakajima M; Uchibori A; Ogawa Y; Miyazaki T; Ichikawa Y; Kaneko K; Takahashi T; Nakashima I; Shiraishi H; Motomura M; Chiba A
Intern Med; 2018 Jun; 57(11):1645-1649. PubMed ID: 29321433
[TBL] [Abstract][Full Text] [Related]
5. Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies.
Honnorat J; Cartalat-Carel S; Ricard D; Camdessanche JP; Carpentier AF; Rogemond V; Chapuis F; Aguera M; Decullier E; Duchemin AM; Graus F; Antoine JC
J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):412-6. PubMed ID: 18931014
[TBL] [Abstract][Full Text] [Related]
6. [Paraneoplastic cerebellar degeneration as the presenting manifestation of breast carcinoma: a case report].
Chaabane K; Turki E; Zouari F; Charfi S; Guermazi M; Mhiri C
Rev Med Interne; 2013 Nov; 34(11):713-5. PubMed ID: 24367813
[TBL] [Abstract][Full Text] [Related]
7. Antiganglioside antibodies in polyneuropathy associated with monoclonal gammopathy.
Eurelings M; Ang CW; Notermans NC; Van Doorn PA; Jacobs BC; Van den Berg LH
Neurology; 2001 Nov; 57(10):1909-12. PubMed ID: 11723289
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic Hu and CRMP5 antibodies are present in smokers without cancer or neurological disease.
Qvale TH; Storstein A; Mazengia K; Eagan TM; Bakke PS; Vedeler CA
Respirology; 2014 Jul; 19(5):730-4. PubMed ID: 24697843
[TBL] [Abstract][Full Text] [Related]
9. Dysimmune neuropathy.
Kwan JY
Front Neurol Neurosci; 2009; 26():67-84. PubMed ID: 19349705
[TBL] [Abstract][Full Text] [Related]
10. [Rapid improvement by rituximab treatment in a case of demyelinating polyneuropathy with anti-myelin-associated glycoprotein antibody].
Motoyama R; Yamakawa K; Suzuki S; Kusunoki S; Tanaka M
Rinsho Shinkeigaku; 2011 Oct; 51(10):761-4. PubMed ID: 22019868
[TBL] [Abstract][Full Text] [Related]
11. Collapsin response mediator protein 5-associated optic neuropathy: clinical characteristics, radiologic clues, and outcomes.
Yan R; Mao Y; Zeng H; Liu Q; Jiang H; Peng J; Yang Q; Cui S; Liu L; Guo Y; Wang J
Front Neurol; 2023; 14():1163615. PubMed ID: 37448746
[TBL] [Abstract][Full Text] [Related]
12. Chronic Demyelinating Polyneuropathies.
Allen JA
Continuum (Minneap Minn); 2017 Oct; 23(5, Peripheral Nerve and Motor Neuron Disorders):1310-1331. PubMed ID: 28968364
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies associated with peripheral neuropathy.
Quarles RH; Weiss MD
Muscle Nerve; 1999 Jul; 22(7):800-22. PubMed ID: 10398197
[TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients.
Camdessanché JP; Antoine JC; Honnorat J; Vial C; Petiot P; Convers P; Michel D
Brain; 2002 Jan; 125(Pt 1):166-75. PubMed ID: 11834602
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic options and management of polyneuropathy associated with anti-MAG antibodies.
Vallat JM; Magy L; Ciron J; Corcia P; Le Masson G; Mathis S
Expert Rev Neurother; 2016 Sep; 16(9):1111-9. PubMed ID: 27267749
[TBL] [Abstract][Full Text] [Related]
16. [Neurologic paraneoplastic syndrome with anti-CV2/CRMP5 antibodies revealing a small cell lung cancer. Effectiveness of the lung cancer treatment].
Rosencher L; Maisonobe T; Lavole A; Milleron B; Ferroir JP
Rev Neurol (Paris); 2012 Apr; 168(4):371-4. PubMed ID: 22387203
[TBL] [Abstract][Full Text] [Related]
17. Remission of demyelinating polyneuropathy with immunoadsorption, low dose corticosteroids and anti-CD20 monoclonal antibody.
Rech J; Hueber AJ; Kallert S; Leipe J; Kalden JR; Beck M; Schett G; Schulze-Koops H
Ther Apher Dial; 2008 Jun; 12(3):205-8. PubMed ID: 18503697
[TBL] [Abstract][Full Text] [Related]
18. Distal acquired demyelinating symmetric (DADS) neuropathy associated with colorectal adenocarcinoma.
Ayyappan S; Day T; Kiers L
Muscle Nerve; 2015 Jun; 51(6):928-31. PubMed ID: 25387811
[TBL] [Abstract][Full Text] [Related]
19. Obinutuzumab, a new anti-CD20 antibody, and chlorambucil are active and effective in anti-myelin-associated glycoprotein antibody polyneuropathy.
Briani C; Visentin A; Salvalaggio A; Cacciavillani M; Trentin L
Eur J Neurol; 2019 Feb; 26(2):371-375. PubMed ID: 30315672
[TBL] [Abstract][Full Text] [Related]
20. CRMP5 antibodies found in a patient with limbic encephalitis and myasthenia gravis.
Monstad SE; Nøstbakken JK; Vedeler CA
J Neurol Neurosurg Psychiatry; 2009 Feb; 80(2):241-2. PubMed ID: 19151024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
